Literature DB >> 33950154

Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals.

Brandon Chalazan1, Denise Mol1, Faisal A Darbar1, Aylin Ornelas-Loredo1, Bahaa Al-Azzam1, Yining Chen1, David Tofovic1, Arvind Sridhar1, Zain Alzahrani1, Patrick Ellinor2, Dawood Darbar1,3,4.   

Abstract

Importance: Although rare variants in cardiac ion channels, transcription factors, and myocardial structural proteins are associated with early-onset atrial fibrillation (AF) in White individuals of European descent, it remains unclear whether genetic variation also contributes to the cause of AF in those of minority ethnicity.
Objectives: To assess the prevalence of rare and novel pathogenic variants in candidate genes in ethnic minority probands with early-onset AF and determine genotype-phenotype associations. Design, Setting, and Participants: In this cohort, family-based study, probands of African and Hispanic descent with early-onset AF (defined as AF occurring in individuals aged ≤66 years) prospectively enrolled in a clinical and genetic biorepository underwent sequencing of 60 candidate genes. Recruitment took place from July 1, 2015, to June 30, 2019. Data were analyzed from February 1 to February 28, 2020. Exposures: Rare and novel variants categorized as pathogenic or likely pathogenic. Main Outcomes and Measures: The prevalence of rare and novel pathogenic variants in African American and Hispanic/Latinx probands with early-onset AF and genotype-phenotype associations.
Results: Among 227 probands with early-onset AF, mean (SD) age at onset of AF was 51.0 (9.9) years, 132 probands (58.1%) were men, 148 (65.2%) were African American, and 79 (34.8%) were Hispanic/Latinx. A family history of AF was verified in 24 probands with early-onset AF (10.6%). Sequencing 60 candidate genes identified 53 (23 rare and 30 novel) variants with 16 of the 227 (7.0%) probands harboring likely pathogenic (43.8%) or pathogenic (56.2%) variants, with most loss-of-function variants in TTN, the gene encoding the sarcomeric protein titin (46.7%). In 6 families with more than 2 affected members, variants of unknown significance in sodium channel (SCN10A), potassium channel (KCNE5), sarcomeric proteins (MYH6 and TTN), and atrial natriuretic peptide (NPPA) cosegregated with AF. Conclusions and Relevance: In this study, likely pathogenic and pathogenic variants were identified, with most loss-of-function variants in TTN, that increase susceptibility to early-onset AF in African American and Hispanic/Latinx individuals. These findings provide further understanding toward molecular phenotyping of AF and suggest novel mechanism-based therapeutic approaches for this common arrhythmia in ethnic minority groups.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33950154      PMCID: PMC8100900          DOI: 10.1001/jamacardio.2021.0994

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  10 in total

1.  Significance of α-Myosin Heavy Chain (MYH6) Variants in Hypoplastic Left Heart Syndrome and Related Cardiovascular Diseases.

Authors:  Melissa Anfinson; Robert H Fitts; John W Lough; Jeanne M James; Pippa M Simpson; Stephanie S Handler; Michael E Mitchell; Aoy Tomita-Mitchell
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-03

2.  Atrial fibrillation.

Authors: 
Journal:  Nat Rev Dis Primers       Date:  2016-03-31       Impact factor: 65.038

3.  PRRX1 Loss-of-Function Mutations Underlying Familial Atrial Fibrillation.

Authors:  Xiao-Juan Guo; Xing-Biao Qiu; Jun Wang; Yu-Han Guo; Chen-Xi Yang; Li Li; Ri-Feng Gao; Zun-Ping Ke; Ruo-Min Di; Yu-Min Sun; Ying-Jia Xu; Yi-Qing Yang
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 6.106

Review 4.  Racial and Ethnic Differences in the Management of Atrial Fibrillation.

Authors:  Kamala P Tamirisa; Sana M Al-Khatib; Sanghamitra Mohanty; Janet K Han; Andrea Natale; Dhiraj Gupta; Andrea M Russo; Amin Al-Ahmad; Anne M Gillis; Kevin L Thomas
Journal:  CJC Open       Date:  2021-09-13

5.  The prevalence of atrial fibrillation in Greenland: a register-based cross-sectional study based on disease classifications and prescriptions of oral anticoagulants.

Authors:  N Albertsen; S Riahi; M L Pedersen; N Skovgaard; S Andersen
Journal:  Int J Circumpolar Health       Date:  2022-12       Impact factor: 1.228

Review 6.  Cytoskeletal Protein Variants Driving Atrial Fibrillation: Potential Mechanisms of Action.

Authors:  Stan W van Wijk; Wei Su; Leonoor F J M Wijdeveld; Kennedy S Ramos; Bianca J J M Brundel
Journal:  Cells       Date:  2022-01-25       Impact factor: 6.600

7.  A novel PRRX1 loss-of-function variation contributing to familial atrial fibrillation and congenital patent ductus arteriosus.

Authors:  Zun-Ping Ke; Gao-Feng Zhang; Yu-Han Guo; Yu-Min Sun; Jun Wang; Ning Li; Xing-Biao Qiu; Ying-Jia Xu; Yi-Qing Yang
Journal:  Genet Mol Biol       Date:  2022-03-30       Impact factor: 1.771

8.  Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC-derived atrial fibrillation model.

Authors:  Olivia T Ly; Hanna Chen; Grace E Brown; Liang Hong; Xinge Wang; Yong Duk Han; Mahmud Arif Pavel; Arvind Sridhar; Mark Maienschein-Cline; Brandon Chalazan; Sang-Ging Ong; Khaled Abdelhady; Malek Massad; Lona Ernst Rizkallah; Jalees Rehman; Salman R Khetani; Dawood Darbar
Journal:  JCI Insight       Date:  2022-04-08

9.  Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes.

Authors:  Zachary T Yoneda; Katherine C Anderson; Fei Ye; Joseph A Quintana; Matthew J O'Neill; Richard A Sims; Lili Sun; Andrew M Glazer; Giovanni Davogustto; Majd El-Harasis; James L Laws; Brittany N Saldivar; Diane M Crawford; Thomas Stricker; Quinn Wells; Dawood Darbar; Gregory F Michaud; Lynne W Stevenson; Steven A Lubitz; Patrick T Ellinor; Dan M Roden; M Benjamin Shoemaker
Journal:  JAMA Cardiol       Date:  2022-07-01       Impact factor: 30.154

10.  Management and outcomes of atrial fibrillation in 241 healthy children and young adults: Revisiting "lone" atrial fibrillation-A multi-institutional PACES collaborative study.

Authors:  Iqbal El Assaad; Benjamin H Hammond; Lukas D Kost; Sarah Worley; Christopher M Janson; Elizabeth D Sherwin; Elizabeth A Stephenson; Christopher L Johnsrude; Mary Niu; Ira Shetty; David Lawrence; Anthony C McCanta; Seshadri Balaji; Shubhayan Sanatani; Frank Fish; Gregory Webster; Peter F Aziz
Journal:  Heart Rhythm       Date:  2021-07-31       Impact factor: 6.779

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.